Method Of Treating Abnormal Cell Growth

Abstract

The present invention relates to the use of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, a novel c-Met/HGFR inhibitor, for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 2, 2010
  • Application: Nov 23, 2006
    US US 9511406 A
  • Priority: Nov 23, 2006
    US US 9511406 A
  • Priority: Nov 23, 2006
    IB IB 2006003397 W
  • Priority: Nov 7, 2006
    US US 86463706 P
  • Priority: Dec 5, 2005
    US US 74276605 P

Download Citation


Sign in to the Lens

Feedback